Key facts
- This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
- 11 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 19 Oct 2022, 16:20.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
Options Exercise
Sale
Sale
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Award
Additional SEC filing notes
Footnote F1
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.
Footnote F2
The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.37 to $40.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.40 to $40.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Footnote F6
One-fourth (1/4th) of the shares subject to the option will vest October 17, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through October 17, 2026, subject to the Reporting Person continuing to provide service through each such date.